Chinese Journal of Nursing ›› 2021, Vol. 56 ›› Issue (6): 855-860.DOI: 10.3761/j.issn.0254-1769.2021.06.009

• Neurological Disease Care • Previous Articles     Next Articles

Reliability and validation study of the Chinese version of M.D. Anderson Symptom Inventory Brain Tumor Module

PU Shuying(),YAO Qianqian,JIANG Wei,LUO Yanfang()   

  • Received:2020-11-21 Online:2021-06-15 Published:2021-06-11
  • Contact: Yanfang LUO

中文版安德森脑肿瘤症状评估量表的信效度检验

蒲树英(),姚芡芡,蒋玮,罗艳芳()   

  1. 400010 重庆市 重庆医科大学附属第二医院康复医学科(蒲树英,蒋玮);昆明医科大学第一附属医院神经外科(姚芡芡,罗艳芳)
  • 通讯作者: 罗艳芳
  • 作者简介:蒲树英:女,本科(硕士在读),主管护师,E-mail:psy101@126.com
  • 基金资助:
    昆明医科大学2020年硕士研究生创新基金项目(2020S168)

Abstract:

Objective To evaluate the reliability and validity of the Chinese version of M.D. Anderson Symptom Inventory Brain Tumor Module(MDASI-BT) as a tool for assessing multiple symptoms in Chinese brain tumor patients. Methods From December 2019 to October 2020,208 patients with primary brain tumor were recruited by convenience sampling method from a tertiary hospital in Yunnan Province for a questionnaire survey,in order to evaluate the reliability and validity of the instrument. Results The Chinese version of MDASI-BT contained 28 items,including 22 symptom assessment items and 6 symptom interference assessment items. Through exploratory factor analysis,6 common factors extracted from 22 symptom assessment items could account for 63.137% of the cumulative variance. One common factor extracted from 6 symptom interference assessment items could explain a cumulative variance of 63.368%. The Cronbach’s α coefficient of the instrument was 0.920,and the split-half reliability was 0.894. Conclusion The Chinese version of MDASI-BT showed high reliability and validity. It can be used as a specific and practical tool for assessing cancer-related symptoms and its disturbance of life in patients with brain tumor.

Key words: Brain Tumor, Symptom, Assessment Tools, Reliability, Validity, Oncologic Nursing Care

摘要:

目的 检验中文版安德森脑肿瘤症状评估量表(M.D. Anderson Symptom Inventory Brain Tumor Module,MDASI-BT)的信效度。 方法 2019年12月—2020年10月,采用便利抽样法对云南省某三级甲等医院208例原发性脑肿瘤患者进行问卷调查,检验量表的信效度。 结果 中文版MDASI-BT共28个条目,包括22个症状评估条目和6个症状干扰评估条目。探索性因子分析结果显示,22个症状评估条目提取6个公因子,累计方差贡献率为63.137%; 6个症状干扰条目提取1个公因子,累计方差贡献率为63.368%。总量表的Cronbach’s α系数为0.920,折半系数为0.894。结论 中文版MDASI-BT具有较好的信效度,可用于脑肿瘤患者症状严重程度及对生活干扰的评估。

关键词: 脑肿瘤, 症状, 评估工具, 信度, 效度, 肿瘤护理